ÂÜÀòÂÒÂ×

Richard J. Shea, MBA, is a 20-year veteran of the life sciences industry and has held a series of diverse leadership roles in both large pharmaceutical companies (Merck) and several start-up and mid-size companies. Rich joined VPI in an advisory capacity in 2006 and accepted the CEO role in early 2009. During his tenure, VPI has closed on a Series A venture funding with top tier firms MPM Capital and Intersouth Partners as co-lead investors and executed two strategic collaborations with Janssen Biotech, a division of Johnson and Johnson Corporation. Rich holds a B.S. degree from the University of Notre Dame (cum laude) and an MBA from Duke University’s Fuqua School of Business (Fuqua Scholar, top 10%).